LAS VEGAS, May 21, 2024--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company"), today announced a $7 million investment in MyMD Pharmaceuticals, Inc ...

Short interest in PharmaCyte Biotech Inc (NASDAQ:PMCB) decreased during the last reporting ... close out their positions without sending the stock sharply higher.

Get PharmaCyte Biotech alerts: PharmaCyte Biotech (NASDAQ:PMCB – Get Free Report) last posted its quarterly earnings data on Monday, March 17th. The company reported ($0.10) earnings per share ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...